Literature DB >> 2859078

Comparison of different strategies for treatment of duodenal ulcer.

A Sonnenberg.   

Abstract

A simple model of a Markov chain was used to study the long term outcome of different strategies for the treatment of duodenal ulcer. Maintenance treatment with H2 receptor antagonists surpassed intermittent drug treatment and proximal gastric vagotomy with respect to the relapse free interval and severe postoperative morbidity. With maintenance treatment the rate of complications and the number of deaths related to ulcer were slightly higher than after proximal gastric vagotomy. Nevertheless, because the few deaths from proximal gastric vagotomy occur at the initiation of treatment the loss of life years during maintenance treatment exceeded that of proximal gastric vagotomy only after 20 years. Despite its rarity, severe postoperative morbidity after proximal gastric vagotomy far exceeded that after the few emergency operations which would become necessary in the course of maintenance treatment. The superiority of maintenance treatment over proximal gastric vagotomy remained insensitive to changes in the assumptions underlying the recurrence rate with both treatments and the postoperative morbidity of proximal gastric vagotomy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859078      PMCID: PMC1418847          DOI: 10.1136/bmj.290.6476.1185

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  24 in total

1.  The Markov process in medical prognosis.

Authors:  J R Beck; S G Pauker
Journal:  Med Decis Making       Date:  1983       Impact factor: 2.583

Review 2.  Evaluation of surgical treatment of duodenal ulcer: short- and long-term effects.

Authors:  J C Thompson; I Wiener
Journal:  Clin Gastroenterol       Date:  1984-05

3.  A prospective randomized trial of vagotomy in chronic duodenal ulceration: 4-year follow-up.

Authors:  C G Koffman; D J Hay; P C Ganguli; J B Elder; I E Gillespie; S M Mantoudis; D E Tweedle; P F Schofield; M Palmer
Journal:  Br J Surg       Date:  1983-06       Impact factor: 6.939

4.  Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: results after 5-7 years.

Authors:  B C De Vries; M E Schattenkerk; E E Smith; J Spencer; D S Jackson; J Alexander-Williams; N J Dorricott
Journal:  Br J Surg       Date:  1983-12       Impact factor: 6.939

5.  Recurrences 1 to 10 years after highly selective vagotomy in prepyloric and duodenal ulcer disease. Frequency, pattern, and predictors.

Authors:  H O Adami; L K Enander; L Enskog; C Ingvar; B Rydberg
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

6.  Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

7.  A comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty--one surgeon's results after 5 years.

Authors:  A G Fraser; P W Brunt; N A Matheson
Journal:  Br J Surg       Date:  1983-08       Impact factor: 6.939

8.  Review of ulcer treatment: role of ranitidine.

Authors:  E J Boyd; J A Wilson; K G Wormsley
Journal:  J Clin Gastroenterol       Date:  1983       Impact factor: 3.062

9.  Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

10.  Cimetidine treatment of recurrent ulcer after proximal gastric vagotomy.

Authors:  A Berstad; E Aadland; K Bjerke
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

View more
  5 in total

1.  Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process.

Authors:  A Sonnenberg; G A Derfus; K H Soergel
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Pyloric stenosis complicating duodenal ulceration.

Authors:  H Ellis
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

3.  Long term H2 antagonists in peptic ulcer disease.

Authors:  G J Cooper; D D Kerrigan; A G Johnson
Journal:  BMJ       Date:  1988-12-17

4.  Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.

Authors:  F Lanza; J Goff; D Silvers; J Winters; N Jhala; D Jennings; P Greski-Rose
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

Review 5.  Deaths from peptic ulceration.

Authors:  T V Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.